Celldex Therapeutics
CLDX
CLDX
54 hedge funds and large institutions have $8.8M invested in Celldex Therapeutics in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.7% less ownership
Funds ownership: 27.12% → 26.42% (-0.7%)
16% less capital invested
Capital invested by funds: $10.4M → $8.8M (-$1.62M)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
Holders
54
Holding in Top 10
1
Calls
$163K
Puts
$134K
Top Buyers
| 1 | +$463K | |
| 2 | +$243K | |
| 3 | +$86K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$72K |
| 5 |
VF
Virtu Financial
New York
|
+$30K |
Top Sellers
| 1 | -$416K | |
| 2 | -$123K | |
| 3 | -$92K | |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$85K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$70.2K |